A Plan To Move Forward

We are at a point where carping about what was or wasn’t done in the past is useless. We have to move forward in ways to savie lives and, at the same time, preventing a deep depression. Many solid ideas are floating around to help make this possible. This is our attempt to combine them into a workable program. 

Segregate and Protect the vulnerable. It would’ve been much better to have done this right from the beginning, but better late than never. Virtually all the at-risk are known to the medical community. Those with underlying conditions young and old have been treated by a doctor. Someone writes their prescriptions. Doctors need to immediately contact patients with instructions to self-quarantine. This should be accompanied by a letter identifying them as at-risk with a barcode, and directions to an online questionnaire to find each person’s ability to comply. Also, this should include a release to share the info with others at the end of the survey. This is needed to resolve medical confidentially issues in allowing others to asist. It would be best if these forms were quickly created at the federal level for speed and uniformity. It would help if there were public service announcements to make people aware of these forms and the need for a quickly filled out questionnaires. This will allow us to know who needs help and support. We can then center maximum efforts keeping them from being exposed. If they’re not exposed, they won’t need the ICU or to be put on ventilators because of Coronavirus. Remember, anyone needing intensive care is a failure to protect them from exposure. Nursing home residents still dying from Covid-19 shows us we haven’t even protected the most easily identifiable at-risk group. 

Extend Testing and Tests.  We need to know who is presently infected, who isn’t, and who has recovered. To identify the infected, we still need to quickly expand the quantity and speed of Covid 19 tests. Also, we need two other types of tests. The polymerase chain reaction test (PCR) presently used to determine the genetic signature of the live virus to identify those very recently infected. Now in development, a serology test studying the serum and other bodily fluids to identify antibodies formed in response to the infection. The knowledge of who is or isn’t infected and who has recovered will provide us with better tools. These can be used to keep the space between people having the disease and those in the greatest danger. Knowing who is immune can be a game-changer. Just having them available to care for the vulnerable would significantly improve safety. The tests will provide us the data to move forward.

Continue reading